February 20, 2026
Projections indicate that, the global monoclonal antibodie market will increase from USD 254.89 billion in 2024 to USD 823.31 billion by 2034, experiencing a CAGR of 12.44% over the next 10 years. The monoclonal antibodies market is expanding due t...
April 21, 2026
Based on market forecasts, the monoclonal antibodies therapeutics sector will expand from USD 265.17 billion in 2024 to USD 1057.91 billion by 2034, experiencing a CAGR of 14.84%. In 2024, North America led the monoclonal antibody therapeutics market...
April 21, 2026
Based on market forecasts, the monoclonal antibodies in veterinary health sector will expand from USD 1.23 billion in 2024 to USD 6 billion by 2034, experiencing a CAGR of 17.13%. In 2024, North America led the veterinary monoclonal antibodies market...
April 24, 2026
Biosimilar Monoclonal Antibodies Market (By Type: Adalimumab, Bevacizumab, Infliximab, Rituximab, Trastuzumab, Others; By Indication: Oncology, Autoimmune diseases, Others; By End User: Hospitals, Cancer treatment centers, Others; By Region: North Am...
May 07, 2026
Biologics Market (By Source: Microbial, Mammalian, Others; By Product: Monoclonal Antibodies, Antisense & RNAi Therapeutics, Vaccines, Recombinant Proteins, Others; By Disease Category: Oncology, Hematological Disorders, Infectious Disorders, Imm...
April 21, 2026
Market insights predict, the biologics safety testing industry is expected to grow from USD 4.03 billion in 2024 to USD 14.45 billion by 2034, driven by a CAGR of 13.64%. The growing demand for biologics and growing research and development activitie...
April 21, 2026
Market insights predict, the oncology biosimilars industry is expected to grow from USD 6.7 billion in 2024 to USD 36.23 billion by 2034, driven by a CAGR of 18.47%. The oncology biosimilars market is witnessing rapid growth, offering similar and c...
February 05, 2026
According to our forecasts, the humanized monoclonal antibody market was valued at USD 170.04 billion in 2025 and is projected to reach USD 190.34 billion in 2026, expanding to USD 525.3 billion by 2035 at a CAGR of 11.94% from 2026 to 2035....
February 09, 2026
According to market projections, the monoclonal antibody for asthma and COPD sector is expected to grow from USD 34.02 billion in 2025 to USD 58.94 billion by 2035, reflecting a CAGR of 5.65%, providing detailed analysis of disease-specific segment...
April 21, 2026
According to market projections, the monoclonal antibody discovery platform sector is expected to grow from USD 3.66 billion in 2025 to USD 11.93 billion by 2035, reflecting a CAGR of 12.55% that covers manufacturers, suppliers, value chain insights,...
January 09, 2026
Market insights predict, the antibodies drug industry is expected to grow from USD 272.3 billion in 2025 to USD 759.36 billion by 2035, driven by a CAGR of 10.8%. The increase in the production of monoclonal antibodies is leading to higher demand for...
April 21, 2026
Market insights predict the global research antibodies industry will increase from USD 1.68 billion in 2024 to USD 2.71 billion by 2034, achieving a CAGR of 4.90%. The rising need for high-quality antibodies for repeatable research is one of the main...
April 21, 2026
According to forecasts, the global polyclonal antibodies market will grow from USD 1.68 billion in 2024 to USD 2.74 billion by 2034, with an expected CAGR of 5.04%. Growing cases of diseases is driving the usage of polyclonal antibodies....
May 26, 2026
Stem Cell Research Antibodies Market (By Product Type: Primary Antibodies, Secondary Antibodies, Conjugated Antibodies; By Source: Mouse, Rabbit, Goat, Rat, Others; By Application: Stem Cell Identification, Cell Signaling Pathway Analysis, Cell Diffe...
April 21, 2026
According to market projections, the global epigenetic antibodies market, valued at USD 2.29 billion in 2024, is anticipated to reach USD 12.01 billion by 2034, growing at a CAGR of 18.04% over the next decade.The epigenetic antibodies market is grow...
May 26, 2026
Multispecific Antibodies (By Therapy Type: Bispecific Antibodies, Trispecific Antibodies, Other Multispecific Antibodies; By Application: Oncology, Autoimmune Diseases, Infectious Diseases, Other Therapeutic Areas; By Drug Class: Monoclonal Antibodie...
April 30, 2026
Biosimilar Antibodies Market (By Molecular Type: Monoclonal Antibodies (mAbs), Fusion Proteins; By Application: Oncology, Autoimmune Diseases, Others; By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies; By Region: Nort...
+1 9197 992 333
+91 93077 85324
